Imaging agent helps predict success of lung cancer therapy

(Stanford Medicine) Doctors contemplating the best therapy for lung cancer patients may soon be able to predict the efficacy of a widely used lung cancer drug based on an imaging agent and a simple scan, according to the findings of a new clinical trial co-led by researchers at the Stanford University School of Medicine.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news